3278 related articles for article (PubMed ID: 6796268)
1. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
Sava G; Giraldi T; Baldini L
Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of 1,2-bis diazoacetyl ethane.
Emanuel NM; Konovalova NP; Djachkovskaya RF
Cancer Treat Rep; 1976 Nov; 60(11):1601-4. PubMed ID: 191190
[TBL] [Abstract][Full Text] [Related]
3. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
Wallace RE; Murdock KC; Angier RB; Durr FE
Cancer Res; 1979 May; 39(5):1570-4. PubMed ID: 427798
[TBL] [Abstract][Full Text] [Related]
4. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
[TBL] [Abstract][Full Text] [Related]
5. Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice.
Giraldi T; Nisi C; Sava G
J Natl Cancer Inst; 1977 Apr; 58(4):1129-30. PubMed ID: 403295
[TBL] [Abstract][Full Text] [Related]
6. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
7. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
8. Isolation of antitumor polysaccharide fractions from Yucca glauca Nutt. (Lilliaceae).
Ali MS; Sharma GC; Asplund RO; Nevins MP; Garb S
Growth; 1978 Jun; 42(2):213-23. PubMed ID: 98392
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
10. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. XI. Experimental antineoplastic activity of N-diazoacetyl-D,L-phenylalanine ethyl ester and of N-diazoacetyl-D,L-phenylalanine hydrazide].
Baldini L; Brambilla G; Cavanna M
Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1672-5. PubMed ID: 5982441
[No Abstract] [Full Text] [Related]
11. Studies of rhenium carboxylates as antitumor agents. Part II. Antitumor studies of bis (mu-propionato) diaquotetrabromodirhenium (III) in tumor-bearing mice.
Eastland GW; Yang G; Thompson T
Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):435-8. PubMed ID: 6668962
[TBL] [Abstract][Full Text] [Related]
12. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of azaserine and DON.
Burchenal JH
Cancer Treat Rep; 1979 Jun; 63(6):1031-2. PubMed ID: 466642
[No Abstract] [Full Text] [Related]
15. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Pierson HF; Meadows GG
Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
[TBL] [Abstract][Full Text] [Related]
16. [Diazo derivates of amino acids and peptides as possible antineoplastic chemotherapeutic agents. III. Activity on Galliera sarcoma of 2 N-diazoacetyl derivatives of glycine in comparison with azaserine and DON].
BALDINI L; BRAMBILLA G; MATTIOLI F
Boll Soc Ital Biol Sper; 1960 Nov; 36():1188-92. PubMed ID: 13686269
[No Abstract] [Full Text] [Related]
17. Antitumor properties of selected 1,2,4-triazine derivatives.
Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
[TBL] [Abstract][Full Text] [Related]
18. On the antitumor activity of gallium and lanthanides.
Anghileri LJ
Arzneimittelforschung; 1975 May; 25(5):793-5. PubMed ID: 1242326
[TBL] [Abstract][Full Text] [Related]
19. [Carcinogenic activity of two N-diazoacetyl derivatives of glycine in newborn Swiss mice].
Brambilla G; Cavanna M; Parodi S; Caraceni CE
Boll Soc Ital Biol Sper; 1970 Mar; 46(5):227-30. PubMed ID: 5457914
[No Abstract] [Full Text] [Related]
20. Antineoplastic activity of diazoacetyl-glycine derivatives.
Baldini L; Brambilla G
Cancer Res; 1966 Aug; 26(8):1754-8. PubMed ID: 5923173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
